Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

X-ray-activated persistent luminescence nanomaterials for NIR-II imaging

Abstract

Persistent luminescence is not affected by background autofluorescence, and thus holds the promise of high-contrast bioimaging. However, at present, persistent luminescent materials for in vivo imaging are mainly bulk crystals characterized by a non-uniform size and morphology, inaccessible core–shell structures and short emission wavelengths. Here we report a series of X-ray-activated, lanthanide-doped nanoparticles with an extended emission lifetime in the second near-infrared window (NIR-II, 1,000–1,700 nm). Core–shell engineering enables a tunable NIR-II persistent luminescence, which outperforms NIR-II fluorescence in signal-to-noise ratios and the accuracy of in vivo multiplexed encoding and multilevel encryption, as well as in resolving mouse abdominal vessels, tumours and ureters in deep tissue (~2–4 mm), with up to fourfold higher signal-to-noise ratios and a threefold greater sharpness. These rationally designed nanoparticles also allow the high-contrast multiplexed imaging of viscera and multimodal NIR-II persistent luminescence–magnetic resonance–positron emission tomography imaging of murine tumours.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: X-ray-activated PL from Ln-PLNPs.
Fig. 2: Controlled structures and compositions of Ln-PLNPs for NIR-II PL investigation.
Fig. 3: NIR-II PL multiplexed encoding with multilayered PLNPs.
Fig. 4: X-ray-activated Ln-PLNPs for in vivo high-contrast PL imaging.

Similar content being viewed by others

Data availability

The data that support the plots within this paper and other findings of this study are available from the corresponding author upon reasonable request. Source data are provided with this paper.

Code availability

The code that has been used for this work is available from the corresponding author upon request.

References

  1. Hong, G., Antaris, A. L. & Dai, H. Near-infrared fluorophores for biomedical imaging. Nat. Biomed. Eng. 1, 0010 (2017).

    Article  CAS  Google Scholar 

  2. Hu, Z. et al. First-in-human liver-tumour surgery guided by multispectral fluorescence imaging in the visible and near-infrared-I/II windows. Nat. Biomed. Eng. 4, 259–271 (2019).

    Article  Google Scholar 

  3. Fan, Y. et al. Lifetime-engineered NIR-II nanoparticles unlock multiplexed in vivo imaging. Nat. Nanotechnol. 13, 941–946 (2018).

    Article  CAS  Google Scholar 

  4. Tian, R. et al. Albumin-chaperoned cyanine dye yields superbright NIR-II fluorophore with enhanced pharmacokinetics. Sci. Adv. 5, eaaw0672 (2019).

    Article  CAS  Google Scholar 

  5. Carr, J. A. et al. Shortwave infrared fluorescence imaging with the clinically approved near-infrared dye indocyanine green. Proc. Natl Acad. Sci. USA 115, 4465–4470 (2018).

    Article  CAS  Google Scholar 

  6. Frangioni, J. V. In vivo near-infrared fluorescence imaging. Curr. Opin. Chem. Biol. 7, 626–634 (2003).

    Article  CAS  Google Scholar 

  7. Lu, L. et al. NIR-II bioluminescence for in vivo high contrast imaging and in situ ATP-mediated metastases tracing. Nat. Commun. 11, 4192 (2020).

    Article  Google Scholar 

  8. Jaunich, M., Raje, S., Kim, K., Mitra, K. & Guo, Z. Bio-heat transfer analysis during short pulse laser irradiation of tissues. Int. J. Heat. Mass. Trans. 51, 5511–5521 (2008).

    Article  Google Scholar 

  9. Zhan, Q. et al. Using 915 nm laser excited Tm3+/Er3+/Ho3+-doped NaYbF4 upconversion nanoparticles for in vitro and deeper in vivo bioimaging without overheating irradiation. ACS Nano 5, 3744–3757 (2011).

    Article  CAS  Google Scholar 

  10. Brown, C. M., Reilly, A. & Cole, R. W. A quantitative measure of field illumination. J. Biomol. Tech 26, 37–44 (2015).

    Article  Google Scholar 

  11. Li, Y., Gecevicius, M. & Qiu, J. Long persistent phosphors—from fundamentals to applications. Chem. Soc. Rev. 45, 2090–2136 (2016).

    Article  CAS  Google Scholar 

  12. Hölsä, J. Persistent luminescence beats the afterglow: 400 years of persistent luminescence. Electrochem. Soc. Interface 18, 42–45 (2009).

    Article  Google Scholar 

  13. Matsuzawa, T., Aoki, Y., Takeuchi, N. & Murayama, Y. A new long phosphorescent phosphor with high brightness, SrAl2O4:Eu2+, Dy3+. J. Electrochem. Soc. 143, 2670–2673 (1996).

    Article  CAS  Google Scholar 

  14. le Masne de Chermont, Q. et al. Nanoprobes with near-infrared persistent luminescence for in vivo imaging. Proc. Natl Acad. Sci. USA 104, 9266–9271 (2007).

    Article  CAS  Google Scholar 

  15. Miao, Q. et al. Molecular afterglow imaging with bright, biodegradable polymer nanoparticles. Nat. Biotechnol. 35, 1102–1110 (2017).

    Article  CAS  Google Scholar 

  16. Li, Z. et al. Direct aqueous-phase synthesis of sub-10 nm ‘luminous pearls’ with enhanced in vivo renewable near-infrared persistent luminescence. J. Am. Chem. Soc. 137, 5304–5307 (2015).

    Article  CAS  Google Scholar 

  17. Maldiney, T. et al. Controlling electron trap depth to enhance optical properties of persistent luminescence nanoparticles for in vivo imaging. J. Am. Chem. Soc. 133, 11810–11815 (2011).

    Article  CAS  Google Scholar 

  18. Rajendran, V. et al. Super broadband near-infrared phosphors with high radiant flux as future light sources for spectroscopy applications. ACS Energy Lett. 3, 2679–2684 (2018).

    Article  CAS  Google Scholar 

  19. Maldiney, T. et al. The in vivo activation of persistent nanophosphors for optical imaging of vascularization, tumours and grafted cells. Nat. Mater. 13, 418–426 (2014).

    Article  CAS  Google Scholar 

  20. Ma, C. et al. The second near-infrared window persistent luminescence for anti-counterfeiting application. Cryst. Growth Des. 20, 1859–1867 (2020).

    Article  CAS  Google Scholar 

  21. Pan, Z., Lu, Y.-Y. & Liu, F. Sunlight-activated long-persistent luminescence in the near-infrared from Cr3+-doped zinc gallogermanates. Nat. Mater. 11, 58–63 (2012).

    Article  CAS  Google Scholar 

  22. Wu, S. et al. Recent advances of persistent luminescence nanoparticles in bioapplications. Nano-Micro Lett. 12, 2–26 (2020).

    Article  CAS  Google Scholar 

  23. Liu, J. et al. Imaging and therapeutic applications of persistent luminescence nanomaterials. Adv. Drug. Deliv. Rev. 138, 193–210 (2019).

    Article  CAS  Google Scholar 

  24. Zhang, H. et al. Tm3+-sensitized NIR-II fluorescent nanocrystals for in vivo information storage and decoding. Angew. Chem. Int. Ed. 58, 10153–10157 (2019).

    Article  CAS  Google Scholar 

  25. Xu, J. et al. 1.2 μm persistent luminescence of Ho3+ in LaAlO3 and LaGaO3 perovskites. J. Mater. Chem. C 6, 11374–11383 (2018).

    Article  CAS  Google Scholar 

  26. Wang, X., Chen, Y., Liu, F. & Pan, Z. Solar-blind ultraviolet-C persistent luminescence phosphors. Nat. Commun. 11, 2040 (2020).

    Article  CAS  Google Scholar 

  27. Abdukayum, A., Chen, J. T., Zhao, Q. & Yan, X. P. Functional near infrared-emitting Cr3+/Pr3+ co-doped zinc gallogermanate persistent luminescent nanoparticles with superlong afterglow for in vivo targeted bioimaging. J. Am. Chem. Soc. 135, 14125–14133 (2013).

    Article  CAS  Google Scholar 

  28. Chen, X., Song, J., Chen, X. & Yang, H. X-ray-activated nanosystems for theranostic applications. Chem. Soc. Rev. 48, 3073–3101 (2019).

    Article  CAS  Google Scholar 

  29. Yang, Y.-M. et al. X-ray-activated long persistent phosphors featuring strong UVC afterglow emissions. Light. Sci. Appl. 7, 88 (2018).

    Article  CAS  Google Scholar 

  30. Cooper, D. R., Capobianco, J. A. & Seuntjens, J. Radioluminescence studies of colloidal oleate-capped β-Na(Gd,Lu)F4:Ln3+ nanoparticles (Ln = Ce, Eu, Tb). Nanoscale 10, 7821–7832 (2018).

    Article  CAS  Google Scholar 

  31. Mandl, G. A. et al. On a local (de-)trapping model for highly doped Pr3+ radioluminescent and persistent luminescent nanoparticles. Nanoscale 12, 20759–20766 (2020).

    Article  CAS  Google Scholar 

  32. Ou, X. et al. High-resolution X-ray luminescence extension imaging. Nature 590, 410–415 (2021).

    Article  CAS  Google Scholar 

  33. Chen, G., Qiu, H., Prasad, P. N. & Chen, X. Upconversion nanoparticles: design, nanochemistry, and applications in theranostics. Chem. Rev. 114, 5161–5214 (2014).

    Article  CAS  Google Scholar 

  34. Wang, F. & Liu, X. Recent advances in the chemistry of lanthanide-doped upconversion nanocrystals. Chem. Soc. Rev. 38, 976–989 (2009).

    Article  CAS  Google Scholar 

  35. Hasse, M. & Schäfer, H. Upconverting nanoparticles. Angew. Chem. Int. Ed. 50, 5808–5829 (2011).

    Article  CAS  Google Scholar 

  36. Lu, Y. et al. Tunable lifetime multiplexing using luminescent nanocrystals. Nat. Photon. 8, 32–36 (2014).

    Article  CAS  Google Scholar 

  37. Urbach, F. Zur Lumineszenz der Alkalihalogenide: II. Messungmethoden 139, 363–372 (1930).

    Google Scholar 

  38. Rezende, M. Vd. S., Montes, P. J. R., Andrade, A. B., Macedo, Z. S. & Valerio, M. E. G. Mechanism of X-ray excited optical luminescence (XEOL) in europium doped BaAl2O4 phosphor. Phys. Chem. Chem. Phys. 18, 17646–17654 (2016).

    Article  CAS  Google Scholar 

  39. Shi, H. F. & An, Z. F. Ultraviolet afterglow. Nat. Photon. 13, 74–75 (2019).

    Article  CAS  Google Scholar 

  40. Chen, Q. et al. All-inorganic perovskite nanocrystal scintillators. Nature 561, 88–93 (2018).

    Article  CAS  Google Scholar 

  41. Chernikov, A. et al. Exciton binding energy and nonhydrogenic Rydberg series in monolayer WS2. Phys. Rev. Lett. 113, 076802 (2014).

    Article  CAS  Google Scholar 

  42. Jiang, Z., Liu, Z., Li, Y. & Duan, W. Scaling universality between band gap and exciton binding energy of two-dimensional semiconductors. Phys. Rev. Lett. 118, 266401 (2017).

    Article  Google Scholar 

  43. McClure, D. S. & Pedrini, C. Excitons trapped at impurity centers in highly ionic crystals. Phys. Rev. B 32, 8465–8468 (1985).

    Article  CAS  Google Scholar 

  44. Schipper, W. J. & Blasse, G. On the recombination mechanism in X-ray storage phosphors based on lanthanum fluoride. J. Lumin. 59, 377–383 (1994).

    Article  CAS  Google Scholar 

  45. Huang, B., Dong, H., Wong, K.-L., Sun, L.-D. & Yan, C.-H. Fundamental view of electronic structures of β-NaYF4, β-NaGdF4, and β-NaLuF4. J. Phys. Chem. C 120, 18858–18870 (2016).

    Article  CAS  Google Scholar 

  46. Andersen, P., Andersen, L. M. & Iversen, L. H. Iatrogenic ureteral injury in colorectal cancer surgery: a nationwide study comparing laparoscopic and open approaches. Surg. Endosc. 29, 1406–1412 (2015).

    Article  Google Scholar 

  47. Minas, V., Gul, N., Aust, T., Doyle, M. & Rowlands, D. Urinary tract injuries in laparoscopic gynaecological surgery; prevention, recognition and management. Obstet. Gynaecol. 16, 19–28 (2014).

    Google Scholar 

  48. de Valk, K. S. et al. A zwitterionic near-infrared fluorophore for real-time ureter identification during laparoscopic abdominopelvic surgery. Nat. Commun. 10, 3118 (2019).

    Article  CAS  Google Scholar 

  49. Smith, A. M., Mancini, M. C. & Nie, S. Second window for in vivo imaging. Nat. Nanotechnol. 4, 710–711 (2009).

    Article  CAS  Google Scholar 

  50. Gnach, A., Lipinski, T., Bednarkiewicz, A., Rybka, J. & Capobianco, J. A. Upconverting nanoparticles: assessing the toxicity. Chem. Soc. Rev. 44, 1561–1584 (2015).

    Article  CAS  Google Scholar 

  51. Liu, Q. et al. 18F-labeled magnetic-upconversion nanophosphors via rare-earth cation-assisted ligand assembly. ACS Nano 5, 3146–3157 (2011).

    Article  CAS  Google Scholar 

  52. Xiudong, Shi et al. Hemoglobin-mediated biomimetic synthesis of paramagnetic O2-evolving theranostic nanoprobes for MR imaging-guided enhanced photodynamic therapy of tumor. Theranostics 10, 11607–11621 (2020).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

F.Z. and D.Z. acknowledge support from the National Key R&D Program of China (grant no. 2017YFA0207303). F.Z. and D.Z. acknowledge support from the National Natural Science Foundation of China (NSFC, grant nos 22088101 and 51961145403). F.Z. acknowledges support by the National Natural Science Foundation of China (NSFC, grant no. 21725502) and the Research Program of Science and Technology Commission of Shanghai Municipality (grant no. 20JC1411700). Y.F. acknowledges support from the National Natural Science Foundation of China (grant no. 21904023) and the Research Program of Science and Technology Commission of Shanghai Municipality (grant no. 19490713100), Y.Y. acknowledges support from the National Natural Science Foundation of China (grant no. 11974097) and H.Z. acknowledges support from the Research Program of Science and Technology Commission of Shanghai Municipality (grant no. 20490710600).

Author information

Authors and Affiliations

Authors

Contributions

F.Z., Y.F. and Y.Y. conceived and designed experiments. P.P. synthesized the nanoparticles and conducted the PL coding experiments. Y.C. and P.P. conducted the imaging of the blood vessels, ureters and tumours. P.P. and C.S. conducted the dual-channel imaging of the organs and multimodel tumour imaging. H.Z., Y.F. and P.P. built the NIR-II imaging system. Xuan Liu and L.L. developed the codes for image processing. P.P., F.Z. and Y.F. wrote the manuscript. F.Z., Y.F., Y.Y., P.P., Xiaogang Liu, M.Z. and H.Z. analysed the results, figures and supplementary information. F.Z., Y.F., Y.Y., P.P., Xiaogang Liu and D.Z. discussed the mechanism of PL in these Ln-based nanoparticles. D.Z. and F.Z. also contributed to the discussions about the experimental approaches to imaging of the blood vessels and ureters. All the authors contributed to discussing and editing the manuscript.

Corresponding authors

Correspondence to Yong Fan, Yanmin Yang or Fan Zhang.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Peer review information Nature Nanotechnology thanks Cyrille Richard and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Extended data

Extended Data Fig. 1 Influence of the excitation light on the persistent luminescence of Ln-PLNPs.

a, NIR-II PL images of Er-PLNPs (NaYF4:3%Er@NaYF4), Nd-PLNPs (NaYF4:1%Nd@NaYF4), Ho-PLNPs (NaYF4:1%Ho@NaYF4) and Tm-PLNPs (NaYF4:1%Tm@NaYF4) after being pre-irradiated with UV light (254 nm and 365 nm, 6 W for 10 min irradiation) or X-rays (~200 Gy). b, the corresponding intensity profiles of NIR-II PL images in a. Due to the large bandgap of fluoride hosts of Ln-PLNPs, high-energy X-rays are necessary to generate persistent luminescence in the NIR-II window.

Extended Data Fig. 2 Persistent luminescence images of various Ln-PLNPs in the visible-NIR region.

a, PL images of centrifuge tubes, filled with hexagonal Er-PLNPs (NaYF4:3%Er@NaYF4), Nd-PLNPs (NaYF4:1%Nd@NaYF4), Ho-PLNPs (NaYF4:1%Ho@NaYF4), and Tm-PLNPs (NaYF4:1%Tm@NaYF4), recorded at different emission bands. b, c, d, Corresponding long-lasting properties of Er-PLNPs, Nd-PLNPs, Ho-PLNPs, and Tm-PLNPs in the VIS emission bands (b), and NIR-II emission bands (c, d) shown in a. bg: background, ROI: region of interest. e, Corresponding NIR-II PL signal intensities of Er-PLNPs, Nd-PLNPs, Ho-PLNPs, and Tm-PLNPs shown in d (n = the number of pixels within the corresponding ROI). Imaging exposure time for VIS and NIR-II images are 1 s and 5 s, respectively. The data are shown as the mean ± s.d.

Source data

Extended Data Fig. 3 Comparison of the influence of crystal phase on NIR-II persistent luminescence.

a, TEM images of cubic and hexagonal Er-PLNPs with core (NaYF4:3%Er) and core-shell (NaYF4:3%Er@NaYF4) structures. b, XRD pattern of cubic and hexagonal core-shell Er-PLNPs. The standard diffraction patterns of hexagonal NaErF4 (JCPDS 27–0689), hexagonal NaYF4 (JCPDS 27–1427), cubic NaErF4 (JCPDS 27–0688) and cubic NaYF4 (JCPDS 27–1428) are included for references. c, Corresponding NIR-II PL decay curves of cubic and hexagonal Er-PLNPs with bare core and core-shell structure. NIR-II PL signals of hexagonal NaYF4:3%Er@NaYF4 were about 13, 20, and 23 times higher than that of cubic NaYF4:3%Er@NaYF4 at 10 min, 30 min, and 50 min, respectively, probably due to a reduced level of crystal defects or internal quenching. Decay curves were abstracted from corresponding NIR-II PL images with 5 s exposure time.

Source data

Extended Data Fig. 4 Influence of storage temperature on the NIR-II persistent luminescence of Er-PLNPs (NaYF4:3%Er@NaYF4) and Nd-PLNPs (NaYF4:1%Nd@NaYF4).

a, Storable NIR-II PL of Er-PLNPs (0.2 mM in cyclohexane) at room temperature and −20 oC as a function of time. b, Storable NIR-II PL of Er-PLNPs and Nd-PLNPs powders (0.2 mM) stored at −20 oC as a function of time. n = 3 independent experiments. NIR-II PL signals were abstracted from corresponding images with 5 s exposure time. The data are shown as the mean ± s.d.

Source data

Extended Data Fig. 5 Persistent luminescence properties of Ln-PLNPs with Yb3+, Pr3+, Tb3+, Dy3+ and Sm3+ as the activators.

a, TEM images of Yb-PLNPs (NaYF4:1%Yb@NaYF4), Pr-PLNPs (NaYF4:1%Pr@NaYF4), Tb-PLNPs (NaYF4:1%Tb@NaYF4), Dy-PLNPs (NaYF4:10%Tb@NaYF4) and Sm-PLNPs (NaYF4:1%Sm@NaYF4), respectively. b, g, l, PL spectra (b), Influence of activator concentration (g), and PL decay curve (l) of Yb-PLNPs. c, h, m, PL spectra (c), Influence of activator concentration (h), and PL decay curve (m) of Pr-PLNPs. d, i, n, PL spectra (d), Influence of activator concentration (i), and PL decay curve (n) of Tb-PLNPs. e, j, o, PL spectra (e), Influence of activator concentration (j), and PL decay curve (o) of Dy-PLNPs. f, k, p, PL spectra (f), Influence of activator concentration (k), and PL decay curve (p) of Sm-PLNPs. n = 3 independent experiments. Yb-PLNPs were imaged using an InGaAs CCD camera with 5 s exposure time; Pr-PLNPs, Tb-PLNPs, Dy-PLNPs and Sm-PLNPs were imaged using a SCMOS camera with 1 s exposure time. The data are shown as the mean ± s.d.

Source data

Extended Data Fig. 6 Synthesis and characterization of multilayered and codoped Ln-PLNPs.

a, Synthesis process and corresponding TEM images of multilayered Er/Nd/Ho-PLNPs. b, Electron energy-loss spectroscopy (EELS) line scan, conducted with HAADF-STEM imaging (inset) on a multilayered Er/Nd/Ho-PLNP, showing that Gd signals in different regions of the crystal are consistent with the designed multilayered structure. c, The corresponding NIR-II PL decay curves of multilayered Er/Nd/Ho-PLNPs in Er-channel, Nd-channel, and Ho-channel, respectively. d, Synthesis process and corresponding TEM images of codoped Er/Nd/Ho-PLNPs. e, The corresponding NIR-II PL decay curves of codoped Er/Nd/Ho-PLNPs in Er-channel, Nd-channel and Ho-channel, respectively. NIR-II PL decay curves were abstracted from corresponding images with 5 s exposure time.

Source data

Extended Data Fig. 7 Influence of sample concentration and temperature on the ratio of persistent luminescence signals.

Although the PL signals of Nd-channel and Ho-channel in multilayered Nd/Ho-PLNPs (NaYF4:1%Ho@NaGdF4@NaYF4:1%Nd@NaGdF4) both decay over time, the PL ratio (INd/IHo) between the two channels is consistent, independent of sample concentration, surrounding temperature and PL signal duration. NIR-II PL decay curves were abstracted from corresponding images with 5 s exposure time.

Extended Data Fig. 8 The biocompatibility of Ln-PLNPs.

a,b, cell viabilities of 4T1 cells (a) and HEK-293 cells (b) incubated with Er-PLNPs and Nd-PLNP for 24 hours. n = 5 independent experiments. C, H&E staining of visceral organs (heart, liver, spleen, lung and kidney), obtained at 24 h post-injection of H2O (100 μL, control group), Er-PLNPs or Nd-PLNPs (0.2 mM in H2O, 100 μL) via the tail vein. These results indicated that Er-PLNPs and Nd-PLNPs have good biocompatibility and low toxicity. The data are shown as the mean ± s.d.

Source data

Extended Data Fig. 9 In vivo NIR-II persistent luminescence and NIR-II fluorescence imaging of tumours using Nd-PLNPs (NaYF4:1%Nd@NaYF4).

a–c, NIR-II PL images (a), NIR-II FL images (b) and optical photos (c) of ultrasmall CT-26 tumours in a living mouse. d, Corresponding intensity profiles of NIR-II PL images in a and NIR-II FL images in b overtime. e, Normalized intensity profiles of NIR-II PL image (t = 10 s) and NIR-II FL image (808 nm laser power: 4 mWcm−2). f, Tumour-to-normal tissue (T/N) ratios of the tumour 2 shown in a and b as a function of time (n = the number of pixels within the corresponding ROI in a and b). Scale bar: 1 cm. Imaging exposure time for PL and FL imaging is 10 s and 0.1 s, respectively. Nd-PLNPs were injected into ultra-small tumors (1.5–3.5 mm) of living mice. NIR-II PL imaging of tumour showed sharper FWHM (0.94-fold for tumour 1, 0.89-fold for tumour 2, and 0.66-fold for tumour 3) than that of NIR-II FL imaging due to reduced background noise without excitation light. Meanwhile, the tumour-to-normal tissue (T/N) ratio recorded from PL imaging reached 437.6 after injection for 10 s, which was ~ 65.3-fold higher than that of NIR-II FL (~ 6.7). Although the T/N ratios decreased with PL signal attenuation, they maintained above ~ 36 over 60 min, which was 7 times higher than the Rose criterion.

Source data

Extended Data Fig. 10 Multimodal imaging of tumours in a living mouse using NaYF4:3%Er@NaGdF4-(18F) probe.

a, HAADF-STEM image of NaYF4:3%Er@NaGdF4 nanoparticles. b, Element mapping of NaYF4:3%Er@NaGdF4 nanoparticles. c, Relaxation rate R1 (1/T1) versus various Gd3+ concentrations of NaYF4:3%Er@NaGdF4 nanoparticles (0.03, 0.06, 0.12, and 0.24 mM) at room temperature. d, PL, MR and PET imaging of the tumour on a living mouse after intratumoural injection of NaYF4:3%Er@NaGdF4-(18F) probe. Scale bar: 1 cm. This is the first investigation of combined PET, MRI and NIR-II PL signals into single nanoparticles for multimodal in vivo imaging of tumours. In comparison, conventional PL materials are mainly large crystals, which are grown at extremely high temperatures (> 1000 °C) and lack nanostructured modulation and designability, thus hampering advanced multimodal bioimaging and biosensing. Because the signals of PET and MRI are affected by 18F and Gd3+, respectively, similar performance to reported 18F-labeled NaGdF4-based probes can be obtained using our NaYF4:3%Er@NaGdF4-(18F) PLNPs. The longitudinal proton relaxation rate (R1) as a function of Gd3+ concentration in our NaYF4:3%Er@NaGdF4 led to a R1 relaxivity of 18.7 mM−1·s−1, which is lower than that of NaGdF4-based probes (28.39 mM−1·s−1)51 but is 5.4-fold higher than that of clinically used Gd-DTPA (3.45 mM−1·s−1)52.

Supplementary information

Supplementary Information

Supplementary Figs. 1–27, Tables 1–5 and references.

Reporting Summary

Supplementary Data

Statistical Source Data of Supplementary Figures 4, 7–10, 20, 17–20, 22 and 27

Source data

Source Data Fig. 2

Statistical Source Data.

Source Data Fig. 3

Statistical Source Data.

Source Data Fig. 4

Statistical Source Data.

Source Data Extended Data Fig. 2

Statistical Source Data.

Source Data Extended Data Fig. 3

Statistical Source Data.

Source Data Extended Data Fig. 4

Statistical Source Data.

Source Data Extended Data Fig. 5

Statistical Source Data.

Source Data Extended Data Fig. 6

Statistical Source Data.

Source Data Extended Data Fig. 8

Statistical Source Data.

Source Data Extended Data Fig. 9

Statistical Source Data.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pei, P., Chen, Y., Sun, C. et al. X-ray-activated persistent luminescence nanomaterials for NIR-II imaging. Nat. Nanotechnol. 16, 1011–1018 (2021). https://doi.org/10.1038/s41565-021-00922-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41565-021-00922-3

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing